Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-02-09 Sale |
2024-02-09 9:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
96,950 | $10.92 | $1,058,694 | 13,058,441 (Direct) |
View |
2024-01-02 Sale |
2024-01-03 4:56 pm |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
3,000,000 | $11.05 | $33,150,000 | 51,929,426 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-04-20 Tax Withholding |
2024-04-23 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
8,515 | $10.46 | 258,697 (Direct) |
View |
2024-04-20 Tax Withholding |
2024-04-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
9,881 | $10.46 | 177,888 (Direct) |
View |
2024-04-20 Tax Withholding |
2024-04-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,002 | $10.46 | 484,200 (Direct) |
View |
Ownership |
2024-04-12 6:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
0 | $0 | 94,527,290 (Direct) |
View |
2024-03-28 Tax Withholding |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,341 | $10.54 | 267,212 (Direct) |
View |
2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
1,856,163 | $6.4 | 5,309,683 (Direct) |
View |
2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
729,081 | $0 | 5,309,683 (Direct) |
View |
2024-03-30 Tax Withholding |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
366,211 | $10.54 | 5,309,683 (Direct) |
View |
2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
994,373 | $6.4 | 1,164,651 (Direct) |
View |
2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
390,579 | $0 | 1,164,651 (Direct) |
View |
2024-03-30 Tax Withholding |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
215,991 | $10.54 | 1,164,651 (Direct) |
View |
2024-03-20 Tax Withholding |
2024-03-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,003 | $10.01 | 500,202 (Direct) |
View |
2024-03-20 Tax Withholding |
2024-03-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,506 | $10.01 | 187,769 (Direct) |
View |
2024-03-20 Tax Withholding |
2024-03-22 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.01 | 990,063 (Direct) |
View |
2024-03-07 Other |
2024-03-07 6:35 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
30,257,723 | $0 | 34,784,621 (Indirect) |
View |
2024-03-07 Other |
2024-03-07 6:09 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
45,821,757 | $0 | 78,858,646 (Indirect) |
View |
2024-03-07 Other |
2024-03-07 5:53 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director 10% Owner |
45,821,757 | $0 | 48,584,883 (Indirect) |
View |
2024-02-28 Tax Withholding |
2024-03-01 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,630 | $11.71 | 269,553 (Direct) |
View |
2024-02-20 Tax Withholding |
2024-02-22 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,508 | $11.54 | 189,275 (Direct) |
View |
2024-02-20 Tax Withholding |
2024-02-22 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,002 | $11.54 | 516,205 (Direct) |
View |
2024-02-20 Tax Withholding |
2024-02-22 9:01 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $11.54 | 1,001,008 (Direct) |
View |
2024-02-09 Exercise |
2024-02-09 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
96,950 | $0 | 13,058,441 (Direct) |
View |
2024-02-09 Exercise |
2024-02-09 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
96,950 | $3.85 | 13,058,441 (Direct) |
View |
2024-01-28 Tax Withholding |
2024-01-30 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,896 | $10.37 | 271,183 (Direct) |
View |
2024-01-19 Option Award |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
1,570 | $0 | 76,339 (Direct) |
View |
2024-01-19 Option Award |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director |
1,328 | $0 | 12,686 (Direct) |
View |
2024-01-19 Option Award |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
1,207 | $0 | 21,538 (Direct) |
View |
2024-01-20 Tax Withholding |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,506 | $10.35 | 190,783 (Direct) |
View |
2024-01-19 Option Award |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
3,366 | $0 | 78,342 (Direct) |
View |
2024-01-20 Tax Withholding |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.35 | 1,011,953 (Direct) |
View |
2024-01-20 Tax Withholding |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
12,377 | $10.35 | 532,207 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
611,393 | $6.4 | 73,633,116 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
275,227 | $0 | 73,633,116 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
251,538 | $11.5 | 73,633,116 (Direct) |
View |
2023-12-27 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
133,911 | $11.58 | 73,633,116 (Direct) |
View |
2023-12-28 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,913 | $11.37 | 273,079 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
85,232 | $6.4 | 4,195,421 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
38,453 | $0 | 4,195,421 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
47,351 | $11.5 | 4,195,421 (Direct) |
View |
2023-12-27 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
22,043 | $11.58 | 4,195,421 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
159,100 | $6.4 | 8,109,865 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
71,365 | $0 | 8,109,865 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
28,411 | $11.5 | 8,109,865 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
13 | $0 | 279,415 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,894 | $11.5 | 279,415 (Direct) |
View |
2023-12-27 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
6 | $11.58 | 279,415 (Direct) |
View |
2023-12-20 Tax Withholding |
2023-12-22 7:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,003 | $9.96 | 544,584 (Direct) |
View |
2023-12-20 Tax Withholding |
2023-12-22 7:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $9.96 | 1,006,488 (Direct) |
View |
2023-12-20 Tax Withholding |
2023-12-22 7:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,364 | $9.96 | 192,282 (Direct) |
View |
2023-11-29 Other |
2023-12-01 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,360 | $9.13 | 277,282 (Direct) |
View |
2023-11-22 Other |
2023-11-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,549 | $8.68 | 577,136 (Direct) |
View |
2023-11-22 Other |
2023-11-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,415 | $8.68 | 195,061 (Direct) |
View |
2023-11-22 Other |
2023-11-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,318 | $8.68 | 1,028,751 (Direct) |
View |
2023-10-30 Other |
2023-11-01 9:39 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,360 | $8.39 | 279,712 (Direct) |
View |